These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1379423)

  • 1. Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives.
    Baba M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; Pauwels R; De Clercq E
    Antiviral Res; 1992 Apr; 17(4):245-64. PubMed ID: 1379423
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
    Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
    Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.
    Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Nakashima H; Mori S
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2356-60. PubMed ID: 1706522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.
    Piras G; Dutschman GE; Im GJ; Pan BC; Chu SH; Cheng YC
    Antimicrob Agents Chemother; 1995 Feb; 39(2):539-41. PubMed ID: 7537030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
    Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.
    Baba M; Shigeta S; Yuasa S; Takashima H; Sekiya K; Ubasawa M; Tanaka H; Miyasaka T; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1994 Apr; 38(4):688-92. PubMed ID: 7518216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains.
    Balzarini J; Baba M; De Clercq E
    Antimicrob Agents Chemother; 1995 Apr; 39(4):998-1002. PubMed ID: 7540384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
    Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-hepatitis B activity of new substituted uracil and thiouracil glycosides.
    Abdel-Aal MT
    Arch Pharm Res; 2010 Jun; 33(6):797-805. PubMed ID: 20607483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance. Molecular pathogenesis and laboratory monitoring.
    D'Aquila RT
    Clin Lab Med; 1994 Jun; 14(2):393-422. PubMed ID: 7523021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy other than reverse transcriptase inhibitors for HIV infection.
    Kaplan JC; Hirsch MS
    Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
    Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
    Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Walker RT; Mori S
    Mol Pharmacol; 1991 Jun; 39(6):805-10. PubMed ID: 1711148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
    Danel K; Larsen E; Pedersen EB; Vestergaard BF; Nielsen C
    J Med Chem; 1996 Jun; 39(12):2427-31. PubMed ID: 8691437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
    Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
    Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
    de Clercq E
    Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV.
    Maruyama T; Demizu Y; Kozai S; Witvrouw M; Pannecouque C; Balzarini J; Snoecks R; Andrei G; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1553-8. PubMed ID: 18066825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication.
    Pauwels R; Andries K; Debyser Z; Kukla M; Schols D; Desmyter J; De Clercq E; Janssen PA
    Biochem Soc Trans; 1992 May; 20(2):509-12. PubMed ID: 1383063
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV active naphthyl analogues of HEPT and DABO.
    Danel K; Nielsen C; Pedersen EB
    Acta Chem Scand (Cph); 1997 Mar; 51(3 Suppl):426-30. PubMed ID: 9210288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.